Page last updated: 2024-11-04

temozolomide and Polyuria

temozolomide has been researched along with Polyuria in 1 studies

Polyuria: Urination of a large volume of urine with an increase in urinary frequency, commonly seen in diabetes (DIABETES MELLITUS; DIABETES INSIPIDUS).

Research Excerpts

ExcerptRelevanceReference
"Temozolomide (TMZ) is an alkylating agent primarily used to treat tumors of the central nervous system."5.39Central diabetes insipidus: a previously unreported side effect of temozolomide. ( Faje, AT; Klibanski, A; Makimura, H; Miller, KK; Nachtigall, L; Wexler, D, 2013)
"Temozolomide (TMZ) is an alkylating agent primarily used to treat tumors of the central nervous system."1.39Central diabetes insipidus: a previously unreported side effect of temozolomide. ( Faje, AT; Klibanski, A; Makimura, H; Miller, KK; Nachtigall, L; Wexler, D, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Faje, AT1
Nachtigall, L1
Wexler, D1
Miller, KK1
Klibanski, A1
Makimura, H1

Other Studies

1 other study available for temozolomide and Polyuria

ArticleYear
Central diabetes insipidus: a previously unreported side effect of temozolomide.
    The Journal of clinical endocrinology and metabolism, 2013, Volume: 98, Issue:10

    Topics: Adult; Antineoplastic Agents, Alkylating; Astrocytoma; Brain Neoplasms; Dacarbazine; Diabetes Insipi

2013